Dexcom CGM Systems-BDF

Gain Control of Your Diabetes with the Dexcom G6 CGM

Dexcom G6 Continuous Glucose Monitor

Dexcom G6, FDA-Permitted for Zero Fingersticks

Complete the form below to find out if you’re eligible for a Dexcom G6 continuous glucose monitoring system from Edwards Health Care Services (EHCS).



The Dexcom G6 eliminates fingersticks for calibration, diabetes treatment decisions, and diabetes management. If glucose alerts/readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

Displays real-time glucose readings, right on your receiver or smart device.

Enables you to know your glucose number and where it’s headed with zero fingersticks.

Has unique sharing capabilities and alerts that are customizable to fit your needs.

Features a slim, water-resistant sensor with an extended 10-day wear time.

The Dexcom G6 is proven to lower A1C and reduce hypoglycemic incidents.

Not sure if you qualify? Complete this quick form!

Apply Today!

*Followers must have compatible smart devices to use the Dexcom Follow app. To view a list of compatible devices, visit dexcom.com/compatibility. †Separate Dexcom Follow app and internet connection required. Internet connectivity required for data sharing. Users should always confirm readings on the Dexcom G6 app or receiver before making treatment decisions.

*If your glucose alerts and readings from Dexcom G6 CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

Refers to the estimated out-of-pocket cost for eligible commercially insured patients for the Dexcom G6 sensor and transmitter when claims are adjudicated as a pharmacy benefit, and includes benefits and offerings through available Dexcom programs, such as the voucher program. Actual cost may vary and is subject to individual insurance coverage.

*Data from collaborator devices and products must be verified by those collaborator devices and products. Users should confirm data and connections with their collaborator devices and products.

1 Shah VN, et al. Diabetes Technol Ther. 2018;20(6): 428-433. 2 Seagrove Partners Q3 2020 Patient Perspectives Survey. 2020: 36. 3 Beck, RW, et al. JAMA. 2017;317(4):371-378. 4 Welsh, J.B. et al. Diabetes Technol Ther. 2019;21(3): 128-132. 5 Dexcom, data on file. Oct. 2020-March 2021. 6 Dexcom, data on file. 2020.

Your Cart